Skip to NavigationSkip to content

Mundipharma appoints Paul Medeiros as head of corporate and business development

Published on: 06/03/12

Mundipharma International has appointed Paul Medeiros as its new head of corporate and business development at its Cambridge, UK site. 

In this position, Medeiros will help corporate growth within Mundipharma’s European network of independent associated companies.

He brings over 19 years of experience in biopharmaceutical business development and a significant track record of success in technology acquisitions. 

He most recently served as senior vice president and chief business officer at AVI BioPharma, an RNA-based therapeutics firm for rare diseases. 

In that role, he was responsible for all business development and licensing activity, establishment of academic and commercial research collaborations, product portfolio planning and corporate strategy development. 

Previously, Medeiros served as VP of global licensing and strategic alliances for Schering-Plough, where he led worldwide product licensing and strategic partnering initiatives in specialist product categories.

Medeiros began his pharma career at Merck, where he held positions in field sales, new product planning and worldwide marketing.


Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches